HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transoral and Transcervical Surgical Innovations in the Treatment of Glottic Cancer.

Abstract
Transoral and transcervical surgery to treat glottic cancer has advanced substantially over the past decade. There have been considerable innovations that enhance vocal function for early disease and airway function for advanced disease. The fiber-based angiolytic 532 nm potassium titanyl phosphate laser has provided a new foundational strategy to maintain high cure rates with enhanced vocal outcomes for the treatment of early glottic disease. For advanced glottic cancer, transplanting cryopreserved aortic homograft to reconstruct wide-field laryngotracheal airway defects can provide an adequate airway caliber such that a long-term tracheotomy can frequently be avoided.
AuthorsSteven M Zeitels
JournalOtolaryngologic clinics of North America (Otolaryngol Clin North Am) Vol. 48 Issue 4 Pg. 677-85 (Aug 2015) ISSN: 1557-8259 [Electronic] United States
PMID26233792 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2015 S. Zeitels. Published by Elsevier Inc. All rights reserved.
Topics
  • Carcinoma, Squamous Cell (pathology, surgery)
  • Humans
  • Laryngeal Neoplasms (surgery)
  • Laryngectomy (methods)
  • Laser Therapy (methods)
  • Lasers, Solid-State (therapeutic use)
  • Organ Sparing Treatments (methods)
  • Treatment Outcome
  • Vocal Cords (pathology)
  • Voice Quality

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: